UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
280.89
-10.45 (-3.59%)
At close: Dec 5, 2025
UCB SA Market Cap
UCB SA has a market cap or net worth of $54.7 billion as of December 8, 2025. Its market cap has increased by 47.72% in one year.
Market Cap
54.70B
Enterprise Value
56.18B
Revenue
8.04B
Ranking
n/a
PE Ratio
34.97
Stock Price
$280.89
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 54.70B, an increase of 4,456.19%. That is a compound annual growth rate of 13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 54.70B | 44.91% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | 19.53B | 30.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 558.58M |
| Glass House Brands | 531.36M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 363.73M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |